GlassScriptPhysician profile
Houssam Farres
NPI 1578780672
$13,376.24
in general payments reported to CMS, 2019-2025
11 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,403 · 2021: $554 · 2022: $1,897 · 2023: $627 · 2024: $7,761 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $3,145 · Food and Beverage: $2,105 · Education: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $3,144.90 |
| Food and Beverage | $2,104.54 |
| Education | $272.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,395.40 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $3,534.99 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Bolton Medical INC | $990.80 | 2022-2025 | Treo Abdominal Stent-Graft System |
| Silk Road Medical, INC. | $985.54 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $457.38 | 2022-2024 | Endurant Iis, Pivox Oblique Lateral Spinal System |
| Cook Medical LLC | $371.23 | 2022 | |
| Endologix LLC | $245.29 | 2019 | |
| Medtronic Vascular, INC. | $134.00 | 2019 | |
| Genzyme Corporation | $110.37 | 2021 | |
| Penumbra, INC. | $98.21 | 2025 | Indigo System |
| Davol INC. | $53.03 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Houssam Farres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.